A type of biomarkers for prostate cancer, called microRNAs (miRNAs), has a unique level in serum from cancer patients. Hence, detecting them will allow us to diagnose prostate cancer earlier. Currently, this type of biomarkers can only be detected by quantitative real-time polymerase chain reaction. However, this technique does not generate reproducible and reliable results when it is used to detect miRNAs at a low level. To be able to reliably quantify prostate cancer-specific miRNAs at a low level, we propose an ultrasensitive strategy that hires non-toxic virus nanoparticles for probing the miRNAs. This strategy is based on the fact that the virus nanoparticles can be engineered to become capable of emitting three different lights and form complex with nanoparticles for capturing the target miRNAs. It is thus possible to detect multiple target miRNAs in one platform because the virus nanoparticles can emit three different fluorescence lights for detecting three different target miRNAs when three different fluorescent molecules are presented on the surface of the virus nanoparticles. Our objective in this project is to develop the new strategy in order to quantify multiple prostate cancer miRNA biomarkers in serum samples, including three target miRNAs specific for the prostate cancer.
We aim to achieve high sensitivity, accuracy, and reproducibility for detecting the prostate cancer biomarkers in serum. This project will develop a new facile method that can precisely detect the prostate cancer biomarkers and thus can be used for early prostate cancer diagnosis.

Public Health Relevance

This project uses human-safe bacteria-specific virus nanoparticles, gold nanoparticles (GNPs) and magnetic microparticles (MMPs) to detect three miRNA molecules (two are prostate cancer specific and one is general for any cancer). The virus nanoparticles are genetically engineered to become light-emitting and GNP-binding. The GNPs and MMPs are modified with molecules that can bind to different segments of the target miRNA molecules. The GNPs and virus nanoparticles form a GNP/virus complex. In the presence of miRNAs, GNP/virus complex and MMPs form a new complex, where there is one-to-one correspondence between the numbers of virus nanoparticles and miRNA molecules. Because the light-emitting virus nanoparticles can be first released from the complex and then converted into a light-emitting structure called plaque in a one-to-one format when infecting bacteria, counting the number of the plaque can determine the number of cancer biomarker miRNAs, which will in turn be used to diagnose prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
7R21CA195607-02
Application #
9070724
Study Section
Nanotechnology Study Section (NANO)
Program Officer
Sorg, Brian S
Project Start
2015-09-01
Project End
2017-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Oklahoma Norman
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
848348348
City
Norman
State
OK
Country
United States
Zip Code
73019
Wang, Zhifang; Ren, Yipeng; Zhu, Ye et al. (2018) A Rapidly Self-Healing Host-Guest Supramolecular Hydrogel with High Mechanical Strength and Excellent Biocompatibility. Angew Chem Int Ed Engl 57:9008-9012
Li, Lihua; Lu, Yao; Jiang, Chunyan et al. (2018) Actively Targeted Deep Tissue Imaging and Photothermal-Chemo Therapy of Breast Cancer by Antibody-Functionalized Drug-Loaded X-Ray-Responsive Bismuth Sulfide@Mesoporous Silica Core-Shell Nanoparticles. Adv Funct Mater 28:
Fu, Yike; Li, Xiang; Ren, Zhaohui et al. (2018) Multifunctional Electrospun Nanofibers for Enhancing Localized Cancer Treatment. Small :e1801183
Ma, Kun; Fu, Duo; Liu, Yajun et al. (2018) Cancer cell targeting, controlled drug release and intracellular fate of biomimetic membrane-encapsulated drug-loaded nano-graphene oxide nanohybrids. J Mater Chem B 6:5080-5090
Zhan, Jiezhao; Wang, Lin; Zhu, Yuchen et al. (2018) Temperature-Controlled Reversible Exposure and Hiding of Antimicrobial Peptides on an Implant for Killing Bacteria at Room Temperature and Improving Biocompatibility in Vivo. ACS Appl Mater Interfaces :
Li, Mei; Wang, Weidan; Zhu, Ye et al. (2018) Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone. Acta Biomater 77:365-379
Shuai, Yajun; Mao, Chuanbin; Yang, Mingying (2018) Protein Nanofibril Assemblies Templated by Graphene Oxide Nanosheets Accelerate Early Cell Adhesion and Induce Osteogenic Differentiation of Human Mesenchymal Stem Cells. ACS Appl Mater Interfaces 10:31988-31997
Diao, Jingjing; OuYang, Jun; Deng, Ting et al. (2018) 3D-Plotted Beta-Tricalcium Phosphate Scaffolds with Smaller Pore Sizes Improve In Vivo Bone Regeneration and Biomechanical Properties in a Critical-Sized Calvarial Defect Rat Model. Adv Healthc Mater 7:e1800441
Lu, Yao; Li, Lihua; Zhu, Ye et al. (2018) Multifunctional Copper-Containing Carboxymethyl Chitosan/Alginate Scaffolds for Eradicating Clinical Bacterial Infection and Promoting Bone Formation. ACS Appl Mater Interfaces 10:127-138
Li, Lejing; Wondraczek, Lothar; Li, Lihua et al. (2018) CaZnOS:Nd3+ Emits Tissue-Penetrating near-Infrared Light upon Force Loading. ACS Appl Mater Interfaces 10:14509-14516

Showing the most recent 10 out of 36 publications